These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 9244332)
1. Clinical recognition and management of patients exposed to biological warfare agents. Franz DR; Jahrling PB; Friedlander AM; McClain DJ; Hoover DL; Bryne WR; Pavlin JA; Christopher GW; Eitzen EM JAMA; 1997 Aug; 278(5):399-411. PubMed ID: 9244332 [TBL] [Abstract][Full Text] [Related]
2. Clinical recognition and management of patients exposed to biological warfare agents. Franz DR; Jahrling PB; McClain DJ; Hoover DL; Byrne WR; Pavlin JA; Christopher GW; Cieslak TJ; Friedlander AM; Eitzen EM Clin Lab Med; 2001 Sep; 21(3):435-73. PubMed ID: 11572137 [TBL] [Abstract][Full Text] [Related]
3. Biological and chemical agents: a brief synopsis. Rosenbloom M; Leikin JB; Vogel SN; Chaudry ZA Am J Ther; 2002; 9(1):5-14. PubMed ID: 11782813 [TBL] [Abstract][Full Text] [Related]
4. The threat of biological terrorism: a public health and infection control reality. Leggiadro RJ Infect Control Hosp Epidemiol; 2000 Jan; 21(1):53-6. PubMed ID: 10656359 [TBL] [Abstract][Full Text] [Related]
5. Confronting bioterrorism: physicians on the front line. Varkey P; Poland GA; Cockerill FR; Smith TF; Hagen PT Mayo Clin Proc; 2002 Jul; 77(7):661-72. PubMed ID: 12108604 [TBL] [Abstract][Full Text] [Related]
6. Medical aspects of bio-terrorism. Balali-Mood M; Moshiri M; Etemad L Toxicon; 2013 Jul; 69():131-42. PubMed ID: 23339855 [TBL] [Abstract][Full Text] [Related]
7. Drugs and vaccines against biological weapons. Conn Med; 2001 Dec; 65(12):719-20. PubMed ID: 11797482 [No Abstract] [Full Text] [Related]
8. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents. Guarner J; Zaki SR J Histochem Cytochem; 2006 Jan; 54(1):3-11. PubMed ID: 16148309 [TBL] [Abstract][Full Text] [Related]
9. Preparedness for a bioterrorism event in Alaska. Part 1: Detection and identification of a biologic event. Funk EA Alaska Med; 2000; 42(4):101-13. PubMed ID: 14593880 [TBL] [Abstract][Full Text] [Related]
13. A procedure for differentiating between the intentional release of biological warfare agents and natural outbreaks of disease: its use in analyzing the tularemia outbreak in Kosovo in 1999 and 2000. Grunow R; Finke EJ Clin Microbiol Infect; 2002 Aug; 8(8):510-21. PubMed ID: 12197873 [TBL] [Abstract][Full Text] [Related]
14. Biowarfare and bioterrorism. Christian MD Crit Care Clin; 2013 Jul; 29(3):717-56. PubMed ID: 23830660 [TBL] [Abstract][Full Text] [Related]
15. Bacteria as agents of biowarfare. How to proceed when the worst is suspected. Tjaden JA; Lazarus AA; Martin GJ Postgrad Med; 2002 Aug; 112(2):57-60, 63-4, 67-70. PubMed ID: 12198754 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous manifestations of biological warfare and related threat agents. McGovern TW; Christopher GW; Eitzen EM Arch Dermatol; 1999 Mar; 135(3):311-22. PubMed ID: 10086453 [TBL] [Abstract][Full Text] [Related]
17. Defending against viruses in biowarfare. How to respond to smallpox, encephalitides, hemorrhagic fevers. Straight TM; Lazarus AA; Decker CF Postgrad Med; 2002 Aug; 112(2):75-6, 79-80, 85-6. PubMed ID: 12198755 [TBL] [Abstract][Full Text] [Related]
18. Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room. Cunha BA Clin Microbiol Infect; 2002 Aug; 8(8):489-503. PubMed ID: 12197871 [TBL] [Abstract][Full Text] [Related]
19. [Biological weapons. II. Smallpox, botulinum toxin, hemorrhagic fever viruses]. Christ W; Stein H Med Monatsschr Pharm; 2003 Jan; 26(1):13-22. PubMed ID: 12577792 [No Abstract] [Full Text] [Related]
20. [Germs and toxins in bioterrorism]. Inoue N Nihon Rinsho; 2003 Feb; 61 Suppl 2():81-91. PubMed ID: 12722194 [No Abstract] [Full Text] [Related] [Next] [New Search]